From: Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
OAR
Dose-volume constraint (% of total volume)
Rectum
V70Gy < 15%
V60Gy < 25%
V50Gy < 50%
Bladder
V70Gy < 20%
V60Gy < 30%
Femoral heads
V50Gy < 10%